Physician profile
Morgan Z Lin
NPI 1235227109
$8,878.26
in general payments reported to CMS, 2019-2025
24 companies · $678 in 2025
The $678 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,756 · 2020: $520 · 2021: $946 · 2022: $550 · 2023: $772 · 2024: $656 · 2025: $678.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,007 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,006.55 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,985.41 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, Watchman Flx, Avvigo Guidance System |
| Abbott Laboratories | $2,323.49 | 2019-2025 | Perclose Prostyle, Aveir |
| Abiomed | $1,018.88 | 2019-2023 | Impella |
| Corindus INC. | $874.94 | 2019 | |
| Shockwave Medical, INC | $306.46 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $234.92 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $221.14 | 2021-2023 | Brilinta |
| Medtronic, INC. | $178.85 | 2021-2024 | Venaseal, Micra |
| Philips North America LLC | $131.15 | 2021-2025 | (Bq9) Coronary Ivus, Angio Ifr |
| Cvrx, INC. | $125.11 | 2025 | Barostim Neo System |
| Biotronik INC. | $104.85 | 2019-2025 | Amvia Edge |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $63.85 | 2019-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $59.21 | 2022 | |
| Stryker Corporation | $46.58 | 2025 | Revcore Thrombectomy Catheter |
| Cardiovascular Systems INC. | $37.62 | 2019-2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiac Dimensions, INC. | $32.12 | 2024 | |
| Getinge USA Sales, LLC | $21.66 | 2022 | |
| Heartflow, INC. | $20.78 | 2025 | |
| Atricure, INC. | $19.89 | 2023 | |
| Kiniksa Pharmaceuticals International, Plc | $15.46 | 2024 | Arcalyst |
| Roche Diagnostics Corporation | $15.25 | 2019 | |
| Medtronic Vascular, INC. | $14.90 | 2020 | |
| Amarin Pharma, INC. | $12.88 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $12.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morgan Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.